Neogen Corporation (NEOG)
NASDAQ: NEOG · Real-Time Price · USD
5.16
-0.04 (-0.77%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Neogen Revenue
Neogen had revenue of $220.98M in the quarter ending February 28, 2025, a decrease of -3.42%. This brings the company's revenue in the last twelve months to $906.00M, down -2.50% year-over-year. In the fiscal year ending May 31, 2024, Neogen had annual revenue of $924.22M with 12.37% growth.
Revenue (ttm)
$906.00M
Revenue Growth
-2.50%
P/S Ratio
1.23
Revenue / Employee
$310,592
Employees
2,917
Market Cap
1.12B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
May 31, 2024 | 924.22M | 101.78M | 12.37% |
May 31, 2023 | 822.45M | 295.29M | 56.01% |
May 31, 2022 | 527.16M | 58.70M | 12.53% |
May 31, 2021 | 468.46M | 50.29M | 12.03% |
May 31, 2020 | 418.17M | 3.98M | 0.96% |
May 31, 2019 | Pro | Pro | Pro |
May 31, 2018 | Pro | Pro | Pro |
May 31, 2017 | Pro | Pro | Pro |
May 31, 2016 | Pro | Pro | Pro |
May 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.90B |
NEOG News
- 2 days ago - Neogen: A Fair Divestment (Rating Upgrade) - Seeking Alpha
- 4 days ago - Neogen Announces Sale of Cleaners & Disinfectants Business - Business Wire
- 16 days ago - Crude Oil Down 4%; Neogen Shares Plunge After Q3 Results - Benzinga
- 16 days ago - Neogen Corporation (NEOG) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 16 days ago - Neogen Q3 Earnings Fall Short On Expectations, Cuts Guidance Amid Macro Headwinds And Tariff Concerns - Benzinga
- 16 days ago - Neogen® Announces CEO Transition - Business Wire
- 16 days ago - Neogen Announces Third-Quarter 2025 Results - Business Wire
- 18 days ago - Neogen® Announces Refinancing of Term Loan and Revolving Credit Facility - Business Wire